Security
PRF Technologies Ltd. Ordinary Shares · PRFX
PRFXNASDAQCommon stockCurrentCIK 1801834Updated Oct 3, 2026
Name history
PAINREFORM LTD. · through Jan 20, 2026
PRFX price & chart
Loading TradingView…
NASDAQ:PRFX on TradingView ↗About the company
We are a specialty pharmaceutical company focused on the reformulation of established therapeutics. Our proprietary extended-release drug-delivery system is designed to provide an extended period of post-surgical pain relief without the need for repeated dose administration while reducing the potential need for the use of opiates. In March 2025, we acquired the business operations related to an AI-driven solar analytics technology, DeepSolar.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 11,998,000Source | 4,525,000Source | 9,930,000Source | 12,328,000Source |
| Property, Plant and Equipment, NetUSD | 30,000Source | 35,000Source | 38,000Source | 44,000Source |
| GoodwillUSD | 186,000Source | — | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 7,405,000Source | — | — | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 3,125,000Source | 4,261,000Source | 8,026,000Source | 4,096,000Source |
| Assets, CurrentUSD | 4,351,000Source | 4,428,000Source | 9,799,000Source | 12,284,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 185,000Source | 157,000Source | 249,000Source | 365,000Source |
| Operating Lease, Right-of-Use AssetUSD | 26,000Source | 62,000Source | 93,000Source | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 2,708,000Source | 2,701,000Source | 2,691,000Source | 1,307,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 0Source | 0Source | 147,000Source | 94,000Source |
| Additional Paid in CapitalUSD | 69,832,000Source | 58,275,000Source | 48,955,000Source | 43,446,000Source |
| Retained Earnings (Accumulated Deficit)USD | -61,289,000Source | -56,451,000Source | -41,863,000Source | -32,519,000Source |
| Stockholders' Equity Attributable to ParentUSD | 8,543,000Source | 1,824,000Source | 7,239,000Source | 11,021,000Source |
| Liabilities and EquityUSD | 11,998,000Source | 4,525,000Source | 9,930,000Source | 12,328,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 2,441,000Source | 2,442,000Source | 2,410,000Source | 1,064,000Source |
| Operating Lease, Liability, CurrentUSD | 21,000Source | 45,000Source | 56,000Source | — |
| Operating Lease, Liability, NoncurrentUSD | — | 0Source | 30,000Source | — |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 747,000Source | — | — | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 1,868,000Source | 1,904,000Source | 1,668,000Source | 356,000Source |
| Short-term InvestmentsUSD | — | — | 0Source | 6,085,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 447,000Source | 310,000Source | 804,000Source | 1,389,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -3,955,000Source | -12,621,000Source | -6,679,000Source | -6,459,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -982,000Source | -13,000Source | 5,991,000Source | -6,006,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 2,000Source | 13,000Source | 9,000Source | 6,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 3,818,000Source | 8,863,000Source | 4,616,000Source | 0Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -1,121,000Source | -3,765,000Source | 3,930,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 3,150,000Source | 4,271,000Source | 8,036,000Source | 4,106,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -2,000Source | 6,000Source | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 16,000Source | 80,000Source | 73,000Source | 285,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | 0Source |
| Amortization of Intangible AssetsUSD | 759,000Source | — | — | — |
| DepreciationUSD | 15,000Source | 16,000Source | 15,000Source | 15,000Source |
| General and Administrative ExpenseUSD | 3,011,000Source | 2,968,000Source | 3,549,000Source | 4,447,000Source |
| GoodwillUSD | 186,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | 8,000Source | 8,000Source | 8,000Source | 9,000Source |
| Net Income (Loss) Attributable to ParentUSD | -5,022,000Source | -14,588,000Source | -9,344,000Source | -8,792,000Source |
| Nonoperating Income (Expense)USD | 108,000Source | 93,000Source | 248,000Source | 86,000Source |
| Other Operating Income (Expense), NetUSD | 108,000Source | — | — | — |
| Payments of Financing CostsUSD | 190,000Source | 1,235,000Source | 932,000Source | 0Source |
| Proceeds from Issuance of Common StockUSD | 4,000,000Source | 1,350,000Source | 0Source | 0Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 17,000Source | — | — | — |
| Cost of Goods and Services Sold | — | — | — | — |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 1,402,000Source | 1,322,000Source | 1,676,000Source | — |
| Operating Income (Loss)USD | -5,122,000Source | -14,673,000Source | -9,584,000Source | -8,869,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -5,014,000Source | -14,580,000Source | -9,336,000Source | -8,783,000Source |
| Income Tax Expense (Benefit)USD | 8,000Source | 8,000Source | 8,000Source | 9,000Source |
| Net Income (Loss) Attributable to ParentUSD | -5,022,000Source | -14,588,000Source | -9,344,000Source | -8,792,000Source |
| Earnings Per Share, BasicUSD per share | -7.47Source | -32.16Source | -7.14Source | -0.82Source |
| Earnings Per Share, DilutedUSD per share | -7.47Source | -32.16Source | -7.14Source | -0.82Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 647,973Source | 453,544Source | 1,308,920Source | 10,661,170Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 647,973Source | 453,544Source | 1,308,920Source | 10,661,170Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 759,000Source | — | — | — |
| General and Administrative ExpenseUSD | 3,011,000Source | 2,968,000Source | 3,549,000Source | 4,447,000Source |
| Interest Income (Expense), NetUSD | — | — | — | 0Source |
| Interest Income, OtherUSD | — | — | — | 160,000Source |
| Management Fee ExpenseUSD | — | — | — | 20,000Source |
| Nonoperating Income (Expense)USD | 108,000Source | 93,000Source | 248,000Source | 86,000Source |
| Other ExpensesUSD | 24,000Source | 0Source | 0Source | 22,000Source |
| Other General and Administrative ExpenseUSD | 55,000Source | 124,000Source | 147,000Source | 172,000Source |
| Other Operating Income (Expense), NetUSD | 108,000Source | — | — | — |
| Research and Development ExpenseUSD | 1,136,000Source | 11,705,000Source | 6,035,000Source | 4,422,000Source |
| Selling and Marketing ExpenseUSD | 163,000Source | — | — | — |